[
    [
        {
            "time": "2022-01-15",
            "original_text": "Top Research Reports for Microsoft, Broadcom & Eli Lilly",
            "features": {
                "keywords": [
                    "Microsoft",
                    "Broadcom",
                    "Eli Lilly"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Top Research Reports for Microsoft, Broadcom & Eli Lilly",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2022-02-20",
            "original_text": "COVID SCIENCE-Common health issues raise risk for severe COVID-19; sudden food aversion in toddlers may be due to COVID",
            "features": {
                "keywords": [
                    "COVID",
                    "health issues",
                    "severe",
                    "food aversion",
                    "toddlers"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "COVID SCIENCE-Common health issues raise risk for severe COVID-19; sudden food aversion in toddlers may be due to COVID",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2022-03-10",
            "original_text": "Lilly's (LLY) Eczema Study on Lebrikizumab Combo Meets Goal",
            "features": {
                "keywords": [
                    "Lilly",
                    "Eczema",
                    "Lebrikizumab",
                    "Combo",
                    "Meets Goal"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly's (LLY) Eczema Study on Lebrikizumab Combo Meets Goal",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2022-04-05",
            "original_text": "Will Lilly and Pfizer be Top Pharma Stocks Again in 2022?",
            "features": {
                "keywords": [
                    "Lilly",
                    "Pfizer",
                    "Pharma",
                    "Stocks"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Will Lilly and Pfizer be Top Pharma Stocks Again in 2022?",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        }
    ]
]